Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Androgens have complex effects on hair growth, promoting it in some areas but causing hair loss in others, and our understanding of this is still evolving.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Male pattern baldness involves smaller hair follicles, larger oil glands, and other tissue changes, but not major blood supply issues.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

New treatments for male hypogonadism are effective and should be personalized.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

New genes and pathways are important for testosterone production and male sexual development.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

Men with Kennedy disease have less chance of hair loss.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

High doses of finasteride cause cell growth and tumors in mice.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Dietary essential fatty acids improved skin and hair conditions and partially corrected fat composition in diabetic mice.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Hormones and genes affect hair growth and male baldness.

Low-dose finasteride may cause fertility issues, but stopping it can improve sperm quality and lead to pregnancy.

Women with AGA have higher lipid levels, increasing heart disease risk.